---
$id: https://graph.org.ai/products/commodity/51112016
$type: Product
source: UNSPSC
code: "51112016"
title: "Sorafenib tosylate"
class: "51112000"
classTitle: "Tyrosine kinase inhibitors"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Sorafenib tosylate

**UNSPSC Code**: 51112016
**Class**: [Tyrosine kinase inhibitors](Tyrosine kinase inhibitors.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a protein kinase inhibitor with the molecular formula C21H16ClF3N4O3.C7H8O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5T62Q3B36J, chemically known as 1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)urea mono(4-methylbenzenesulfonate), but more generally known as sorafenib tosylate, which bears US NIH Compound Identifier 216239. European Medicines Agency schedules sorafenib tosylate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB23139. Sorafenib tosylate bears US NLM identifiers UMLS ID C1676709 and NCI Concept Code C2194. Most nations, for tariff purposes, schedule sorafenib tosylate under HS 29333999. SMILES: CC1CCC(CC1)S(=O)(=O)O.CNC(=O)C1CC(CCN1)OC2CCC(CC2)NC(=O)NC3CCC(C(C3)C(F)(F)F)CL.

